Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Arcturus Therapeutics Holdings (ARCT) over the last 3 years, with Q2 2025 value amounting to 0.31%.

  • Arcturus Therapeutics Holdings' Return on Invested Capital rose 400.0% to 0.31% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.31%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.37% for FY2024, which is 900.0% down from last year.
  • Arcturus Therapeutics Holdings' Return on Invested Capital amounted to 0.31% in Q2 2025, which was up 400.0% from 0.34% recorded in Q1 2025.
  • In the past 5 years, Arcturus Therapeutics Holdings' Return on Invested Capital ranged from a high of 0.21% in Q3 2023 and a low of 0.46% during Q1 2024
  • Over the past 3 years, Arcturus Therapeutics Holdings' median Return on Invested Capital value was 0.33% (recorded in 2025), while the average stood at 0.28%.
  • In the last 5 years, Arcturus Therapeutics Holdings' Return on Invested Capital plummeted by -5200bps in 2024 and then soared by 1200bps in 2025.
  • Arcturus Therapeutics Holdings' Return on Invested Capital (Quarter) stood at 0.3% in 2023, then decreased by -28bps to 0.38% in 2024, then grew by 18bps to 0.31% in 2025.
  • Its last three reported values are 0.31% in Q2 2025, 0.34% for Q1 2025, and 0.38% during Q4 2024.